4D Molecular Therapeutics, Inc.
← Back to FDMT Overview

4D Molecular Therapeutics, Inc. (FDMT)

Solvency & Capital Structure

Total Debt

$20.5M

Net Debt

-$370.4M

4D Molecular Therapeutics, Inc. currently has $20.5M in total debt. Net debt is -$370.4M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

FDMTQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-310.020.39-0.37Net Cash0.514.0%
2025-12-310.020.40-0.38Net Cash0.573.8%
2025-09-300.020.31-0.28Net Cash0.425.3%
2025-06-300.020.29-0.27Net Cash0.474.9%
2025-03-310.020.32-0.30Net Cash0.524.6%
2024-12-310.020.42-0.40Net Cash0.564.4%
2024-09-300.020.50-0.48Net Cash0.604.1%
2024-06-300.010.54-0.53Net Cash0.622.2%
2024-03-310.010.53-0.51Net Cash0.632.2%
2023-12-310.010.29-0.27Net Cash0.344.3%
2023-09-300.020.32-0.30Net Cash0.364.2%
2023-06-300.020.31-0.29Net Cash0.354.4%
2023-03-310.020.20-0.18Net Cash0.246.4%
2022-12-310.020.21-0.20Net Cash0.266.2%
2022-09-300.020.23-0.21Net Cash0.285.9%
2022-06-300.020.24-0.22Net Cash0.305.6%
2022-03-310.020.24-0.22Net Cash0.325.2%
2021-12-310.020.25-0.23Net Cash0.354.7%
2021-09-300.000.16-0.16Net Cash0.240.0%
2021-06-300.000.24-0.24Net Cash0.250.0%
2021-03-310.000.26-0.26Net Cash0.270.0%
2020-12-310.000.28-0.28Net Cash0.290.0%
2020-09-300.000.09-0.09Net Cash0.100.0%
2020-03-310.000.05-0.05Net Cash0.00
2019-12-310.000.05-0.05Net Cash0.060.0%
2019-09-300.000.07-0.07Net Cash0.00
2019-06-300.000.07-0.07Net Cash0.080.0%
2019-03-310.000.07-0.07Net Cash0.080.0%
2018-12-310.000.09-0.09Net Cash0.100.0%
2018-09-300.000.09-0.09Net Cash0.100.0%
2018-03-310.000.02-0.02Net Cash0.00
4D Molecular Therapeutics, Inc. (FDMT) Debt History — Total Debt & Net Debt Analysis